PVD News

AMERICAN DIABETES ASSOCIATION

Diabetes is the single greatest factor in amputations—more than 60 percent of non-traumatic lower limb amputations happen in the diabetes population. An individual who has had an amputation has a worse chance of five-year survival than someone with coronary artery disease, breast cancer, and colorectal cancer. Amputations in the United States are also substantially more prevalent among people of color.

DIAGNOSTIC AND INTERVENTIONAL CARDIOLOGY

Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference have been announced. Leading physicians and researchers will present results from 21 clinical trials, from Monday, October 31, to Wednesday, November 2, at Wynn Las Vegas.

CARDIOVASCULAR COALITION

September is Peripheral Artery Disease (PAD) Awareness Month! PAD is a chronic circulatory condition, which if left untreated can result in unnecessary limb amputations. PAD affects nearly 20 million Americans, and an estimated 200,000 of them – disproportionately from minorities communities – suffer avoidable amputations every year.

CUREUS

Abstract: Peripheral vascular disease (PVD) is chronic limb ischemia caused by atherosclerosis of the peripheral arteries. Diabetes mellitus (DM) is a risk factor for this disease. The probability of a diabetic foot ulcer (DFU) is higher in a patient with DM and PVD than in a patient without DM. Ankle-brachial-pressure index (ABPI) allows the measurement of blood flow towards the distal extremities, which could help timely diagnosis, initiate brief therapy, and minimize the risk of critical limb ischemia and loss. This study aims to determine the prevalence of peripheral vascular diseas...

THE CLINICAL ADVISOR

Walking at high intensity improved leg function among people with peripheral artery disease (PAD), according to research published in the Journal of the American Heart Association. “We were surprised by the results because walking for exercise at a pace that induces pain in the legs among people with PAD has been thought to be damaging to leg muscles,” said senior study author...

APPLIEDRADIOLOGY

Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial, demonstrating that the Philips endovascular system – Tack (4F) – provides a sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia (CLI), a severe stage of peripheral arterial disease (PAD), out to three years of clinical follow-up.

TCTMD

Compared with angiography alone, adding IVUS imaging to femoropopliteal artery interventions with drug-coated balloons (DCBs) results in less binary restenosis at 1 year, according to results from a single-center RCT. Yet the benefit wasn’t seen for procedures involving plain old balloon angioplasty (POBA) or stenting.

EURASIA REVIEW

Researchers at the University and the University Hospital of Bonn have developed a method that could be used to diagnose atherosclerosis. Using self-learning software, they were able to identify vascular changes in patients with peripheral arterial disease (PAD), often at an early stage. Although these early stages do not yet cause symptoms, they are nevertheless already associated with increased mortality. The algorithm used photos from an organ not normally associated with PAD: the eye. The results have now been published in the journal Scientific Reports.

GLOBE NEWSWIRE

TheWaytoMyHeart.org, a national non-profit Peripheral Artery Disease (PAD) patient advocacy group out of California, announced today that February 19, 2022 will be the first annual national “Red Sock Day” building awareness for Peripheral Artery Disease (PAD), its patients and treatment. The official proclamation will take place Wednesday February 16 at 10 am CST.

PAD is a disease that affects over 12 million Americans. Left untreated, PAD can lead to resting leg pain, foot wounds that won’t heal, gangrene and even amputation. Yet the majority of cases go undiagnosed, in part du...

VASCULAR NEWS

At this year’s International Symposium on Endovascular Therapy (ISET 2022; 16–19 January, Hollywood, USA), experts presented an array of late-breaking trial results on topics ranging from venous stenting to abdominal aortic aneurysm (AAA) sac sealing. Waseem Wahood (Dr Kiran C Patel College of Allopathic Medicine, Davie, USA) gave a US national perspective on disparities in the treatment of peripheral arterial disease (PAD) and chronic limb-threatening ischaemia (CLTI).